Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$415M |
| 2 |
Eli Lilly
LLY
|
+$402M |
| 3 |
Goldman Sachs
GS
|
+$384M |
| 4 |
McDonald's
MCD
|
+$379M |
| 5 |
Tesla
TSLA
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.98B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 3 |
AT&T
T
|
+$460M |
| 4 |
Synchrony
SYF
|
+$398M |
| 5 |
Honeywell
HON
|
+$342M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.53% |
| 2 | Financials | 4.78% |
| 3 | Healthcare | 3.89% |
| 4 | Industrials | 3.6% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
PUT
Blackstone
BX
$102B
| $37.4M | 0.02% |
1,068,800
-189,300
| -15% | -$6.32M |
|
|
CBAY
827
DELISTED
Cymabay Therapeutics
CBAY
| $37.3M | 0.02% |
2,805,472
+1,379,650
| +97% | +$14.7M |
|
828
PUT
Prudential Financial
PRU
$42.4B
| $37.1M | 0.02% |
404,100
+189,800
| +89% | +$17.5M |
|
|
829
CALL
Honeywell
HON
$77B
| $37M | 0.02% |
246,895
+86,260
| +54% | +$12.1M |
|
830
Ovintiv
OVV
$17.3B
| $36.9M | 0.02% |
1,019,771
-3,101,428
| -75% | -$106M |
|
|
DLPH
831
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $36.8M | 0.02% |
1,913,183
-1,263,162
| -40% | -$23.4M |
|
832
Amgen
AMGN
$208B
| $36.8M | 0.02% |
193,620
-118,102
| -38% | -$22.6M |
|
833
PUT
Elevance Health
ELV
$81.5B
| $36.8M | 0.02% |
128,100
+65,300
| +104% | +$18.9M |
|
834
LyondellBasell Industries
LYB
$20B
| $36.7M | 0.02% |
436,025
+339,077
| +350% | +$29.3M |
|
835
CALL
Marathon Petroleum
MPC
$92.4B
| $36.7M | 0.02% |
612,500
+7,000
| +1% | +$440K |
|
836
PUT
US Bancorp
USB
$98.2B
| $36.5M | 0.02% |
757,600
-38,700
| -5% | -$1.94M |
|
837
AnaptysBio
ANAB
$1.58B
| $36.2M | 0.02% |
496,067
+23,502
| +5% | +$1.62M |
|
838
CALL
Best Buy
BBY
$18.2B
| $36.2M | 0.02% |
508,800
-109,100
| -18% | -$6.8M |
|
839
CALL
Intuit
INTU
$86.5B
| $36M | 0.02% |
137,900
-22,400
| -14% | -$5.18M |
|
840
Coca-Cola Europacific Partners
CCEP
$48.3B
| $36M | 0.02% |
695,862
+215,805
| +45% | +$10.2M |
|
841
Ascendis Pharma A/S
ASND
$16B
| $36M | 0.02% |
305,876
+209,267
| +217% | +$18.3M |
|
842
CALL
Zimmer Biomet
ZBH
$18.2B
| $36M | 0.02% |
290,254
+237,415
| +449% | +$27M |
|
|
BHVN
843
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $36M | 0.02% |
698,775
-239,464
| -26% | -$10.3M |
|
844
PUT
RH
RH
$3.13B
| $36M | 0.02% |
349,300
+66,100
| +23% | +$9M |
|
845
CALL
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$154M
| $35.9M | 0.02% |
19,150
+14,517
| +313% | +$32M |
|
846
CALL
NXP Semiconductors
NXPI
$57.8B
| $35.8M | 0.02% |
405,200
-352,500
| -47% | -$31M |
|
847
PUT
Kinder Morgan
KMI
$71.7B
| $35.7M | 0.02% |
1,784,100
-714,000
| -29% | -$13.3M |
|
848
CALL
Southwest Airlines
LUV
$22B
| $35.7M | 0.02% |
687,600
+61,200
| +10% | +$3.23M |
|
849
CALL
MongoDB
MDB
$27.1B
| $35.7M | 0.02% |
242,700
+133,100
| +121% | +$13.7M |
|
850
CALL
Illumina
ILMN
$31B
| $35.7M | 0.02% |
118,014
-29,915
| -20% | -$8.72M |
|
Similar funds
Citadel Advisors's Q1 2019 Portfolio in Review
As of Q1 2019, Citadel Advisors held 10,449 positions worth $201B, up 10% from $183B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Citadel Advisors withdrew a net $12.7B in Q1 2019, closing 1,252 positions and reducing 3,810 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $223M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.5% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Citadel Advisors opened a new position in Elanco Animal Health worth $251M.
- Citadel Advisors's largest Q1 2019 buy was Elanco Animal Health: 7,832,197 shares worth $251M.
- Citadel Advisors added most to Walt Disney in Q1 2019, an estimated $415M increase.
- Citadel Advisors's biggest Q1 2019 reduction was Amazon, cutting an estimated $1.98B.
- Citadel Advisors fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $223M.
- Citadel Advisors's ten largest holdings make up 24% of its $201B portfolio in Q1 2019.
- Citadel Advisors opened 1,430 new positions and closed 1,252 in Q1 2019.
- Citadel Advisors's portfolio value rose 10% quarter-over-quarter to $201B.
Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.